Anixa Biosciences, Inc. (ANIX)
Anixa Biosciences Market Cap : 96.23M for April 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GT Biopharma, Inc. | 12.14M |
| Kyntra Bio, Inc. | 29.87M |
| ACADIA Pharmaceuticals, Inc. | 3.753B |
| Agenus, Inc. | 182.01M |
| Alnylam Pharmaceuticals, Inc. | 45.01B |
Market Cap Related Metrics
| Price to Book Value | 6.382 |
| Price | 2.87 |
| Earnings Yield | -10.97% |